Notice2022-16152
Request for Information (RFI): Inviting Comments and Suggestions on an ODS Strategic Plan 2022-2026
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 28, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
Since its inception in 1994, the National Institutes of Health (NIH), Office of Dietary Supplements (ODS) has used a structured planning process to develop five-year strategic plans. ODS is committed to engaging its stakeholders including representatives of the scientific community, industry, other federal agencies, and the public in the strategic planning process by soliciting their comments on the draft ODS Strategic Plan for Fiscal Years (FY) 2022-2026. Considering comments from representative stakeholder groups, and the general public will help ODS assess the outcomes of its investments and prioritize plans for the next five years.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 144 (Thursday, July 28, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 144 (Thursday, July 28, 2022)]
[Notices]
[Pages 45345-45346]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-16152]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information (RFI): Inviting Comments and Suggestions
on an ODS Strategic Plan 2022-2026
AGENCY: National Institutes of Health, HHS.
ACTION: Request for information.
-----------------------------------------------------------------------
SUMMARY: Since its inception in 1994, the National Institutes of Health
(NIH), Office of Dietary Supplements (ODS) has used a structured
planning process to develop five-year strategic plans. ODS is committed
to engaging its stakeholders including representatives of the
scientific community, industry, other federal agencies, and the public
in the strategic planning process by soliciting their comments on the
draft ODS Strategic Plan for Fiscal Years (FY) 2022-2026. Considering
comments from representative stakeholder groups, and the general public
will help ODS assess the outcomes of its investments and prioritize
plans for the next five years.
DATES: The RFI is open for public comments and must be received by
11:59:59 p.m. (ET) on August 31, 2022, to ensure consideration.
ADDRESSES: All comments must be submitted electronically to
<a href="/cdn-cgi/l/email-protection#08676c7b7864696648676c26666160266f677e"><span class="__cf_email__" data-cfemail="6e010a1d1e020f002e010a4000070640090118">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to:
Barbara Cohen at <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e6a9a2b5968a8788a68982c8888f8ec8818990">[email protected]</a> or (301) 435-2920.
SUPPLEMENTARY INFORMATION: This notice is in accordance with the 21st
Century Cures Act, wherein NIH institutes are required to regularly
update their strategic plans. The purpose of the FY 2022-2026 ODS
Strategic Plan (<a href="https://ods.od.nih.gov/About/StrategicPlan.aspx">https://ods.od.nih.gov/About/StrategicPlan.aspx</a>) is to
communicate how ODS will advance its mission to support, coordinate,
and disseminate the results of scientific research, and provide
leadership to help expand the knowledge, scientific evidence, and
understanding of dietary supplements, thus fostering an enhanced
quality of life and health for the U.S. population. The plan
articulates ODS' priorities in five key areas (goals):
(1) Expand the scientific knowledge base on dietary supplements by
stimulating and supporting a full range of biomedical research and by
developing and contributing to relevant initiatives, workshops,
meetings, and conferences;
(2) Enhance the dietary supplement research workforce through
training and career development and simultaneously support the
development of programs for diverse researchers who are
underrepresented in science;
(3) Foster development and dissemination of research resources and
tools to enhance the quality of dietary supplement research;
(4) Translate dietary supplement research findings into useful
information for consumers, health professionals, researchers, and
policymakers; and
(5) Coordinate and support the development of collaborative
initiatives to address gaps in dietary supplement research.
ODS has completed a draft of its Five-Year Strategic Plan for FY
2022-2026 (<a href="https://ods.od.nih.gov/About/StrategicPlan.aspx">https://ods.od.nih.gov/About/StrategicPlan.aspx</a>) and is
interested in receiving feedback from all interested parties on the
following:
<bullet> Are there additional emerging public health issues that
ODS can help address?
<bullet> Are there existing knowledge gaps that ODS can help
address (not included in the current plan)?
<bullet> What can ODS do better to meet the needs of its
stakeholders?
ODS encourages organizations to submit a single response reflective
of the views of the organization as a whole.
Responses to this RFI are voluntary and may be submitted
anonymously. Please do not include any personally identifiable
information or any information that you do not wish to make public.
Proprietary, classified, confidential, or sensitive information should
not be included in your response. The NIH will use the information
submitted in response to this RFI at its discretion. The NIH reserves
the right to use any submitted information on public websites, in
reports, in summaries of the state of the science, in any possible
resultant solicitation(s), grant(s), or cooperative agreement(s), or in
the development of future funding opportunity announcements. This RFI
is for informational and planning purposes only and is not a
solicitation for applications or an obligation on the part of the
Government to provide support for any ideas identified in response to
it. Please note that the Government will not pay for the preparation of
any information submitted or for use of that information.
We look forward to your input and hope that you will share this RFI
opportunity with your colleagues.
[[Page 45346]]
Dated: July 22, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2022-16152 Filed 7-27-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 28, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.